Quest Diagnostics
496 hedge funds and large institutions have $8.72B invested in Quest Diagnostics in 2014 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 174 increasing their positions, 176 reducing their positions, and 45 closing their positions.
49% more call options, than puts
Call options by funds: $160M | Put options by funds: $108M
20% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 45
17% more funds holding in top 10
Funds holding in top 10: 6 → 7 (+1)
1% more funds holding
Funds holding: 491 → 496 (+5)
2% more capital invested
Capital invested by funds: $8.54B → $8.72B (+$185M)
1% less repeat investments, than reductions
Existing positions increased: 174 | Existing positions reduced: 176
1.91% less ownership
Funds ownership: 104.75% → 102.83% (-1.9%)
Top Buyers
| 1 |
Bank of America
Charlotte,
North Carolina
|
+$341M |
| 2 |
DSA
Davis Selected Advisers
Tucson,
Arizona
|
+$268M |
| 3 |
Norges Bank
Oslo,
Norway
|
+$74.1M |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$49.1M |
| 5 |
ACM
Addison Clark Management
Stamford,
Connecticut
|
+$42.3M |
Top Sellers
DGX Hedge Fund Activity: Q2 2014 in Review
496 of the 3,479 institutional investors tracked by Wall St. Rank reported a position in Quest Diagnostics (DGX) for Q2 2014, worth a combined $8.72B — up 2.2% from $8.54B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new DGX positions and 45 closed out — a net gain of 9 holders — while 174 added to existing stakes and 176 trimmed.
The largest buyer was Bank of America, adding an estimated $341M. The largest seller was Aberdeen Asset Management, cutting an estimated $386M.
- 496 institutional investors held Quest Diagnostics (DGX) as of Q2 2014, up from 491 in Q1 2014.
- Funds reported $8.72B of Quest Diagnostics stock for Q2 2014, up 2.2% quarter-over-quarter.
- 54 funds opened new Quest Diagnostics positions in Q2 2014 and 45 closed out, a net change of +9 holders.
- The largest Quest Diagnostics buyer in Q2 2014 was Bank of America, an estimated $341M added.
- The largest Quest Diagnostics seller in Q2 2014 was Aberdeen Asset Management, an estimated $386M sold.
Based on aggregated 13F filings for Q2 2014.